Author

D. Thakkar

Indian Institute of Technology Gandhinagar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1 Organism:virus· 1

Frequent Co-Authors

A. D. T. Barrett· 1 shared A. P. C. Lim· 1 shared Achinta SannigrahiiD· 1 shared Arijit Patra· 1 shared B. J. Hanson· 1 shared B. Young· 1 shared C. E. Z. Chan· 1 shared C.-T. K. Tseng· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. D. T. Barrett

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Membrane Fusion Inhibition, Immune Modulation, and Cholesterol Synthesis Dysregulation During Dengue Virus Inhibition by 25-Hydroxycholesterol

Debayani Chakraborty, Achinta Sannigrahi, Mahammed Kaif, Arijit Patra, D. Thakkar, Debarati Chakraborty, Rahul Roy

This study shows 25-hydroxycholesterol inhibits dengue virus by disrupting membrane fusion, modulating cholesterol metabolism, and enhancing innate immunity.

bioRxiv · May 31, 2025 · PreprintCell Biology

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody

C. E. Z. Chan, S. G. K. Seah, D. H. Chye, S. Massey, M. Torres, A. P. C. Lim, S. K. K. Wong, J. J. Y. Neo, P. S. Wong, J. H. Lim, G. S. L. Loh, D. L. Wang, J. D. Boyd-Kirkup, S. Guan, D. Thakkar, , B. J. Hanson

The paper identifies SC31, a potent SARS-CoV-2 neutralizing antibody, and shows that its Fc-mediated effector functions are critical for its therapeutic efficacy in vivo.

bioRxiv · Oct 26, 2020Microbiology